Benzocaine: Indication, Dosage, Side Effect, Precaution

Generic Medicine Info Full Generic Medicine Info

Dosage/Direction for Use Contraindications Special Precautions Adverse Reactions Overdosage Drug Interactions Action Storage CIMS Class ATC Classification

This information is not country-specific. Please refer to the India prescribing information.

Generic Medicine Info

Contraindications

Epiglottis (oral spray), methaemoglobinaemia.

Special Precautions

Patient w/ asthma, bronchitis, emphysema, heart disease; smokers. Childn. Pregnancy and lactation. Monitoring Parameters Monitor for signs and symptoms of methaemoglobinaemia.

Adverse Reactions

Localised burning or erythema, stinging sensation, contact dermatitis, rash, urticaria, methaemoglobinaemia, oedema, tenderness.

Drug Interactions

May antagonise the therapeutic effect of sulfonamides. Anticholinesterases may inhibit the metabolism benzocaine.

CIMS Class

Anaesthetics- local & general / Mouth/Throat Preparations / Other Ear Preparations

ATC Classification

D04AB04 - benzocaine ; Belongs to the class of topical anesthetics used in the treatment of pruritus.
C05AD03 - benzocaine ; Belongs to the class of local anesthetics. Used in the topical treatment of hemorrhoids and anal fissures.
R02AD01 - benzocaine ; Belongs to the class of local anesthetics used in throat preparations.
N01BA05 - benzocaine ; Belongs to the class of esters of aminobenzoic acid. Used as local anesthetics.

Disclaimer: This information is independently developed by CIMS based on benzocaine from various references and is provided for your reference only. Therapeutic uses, prescribing information and product availability may vary between countries. Please refer to CIMS Product Monographs for specific and locally approved prescribing information. Although great effort has been made to ensure content accuracy, CIMS shall not be held responsible or liable for any claims or damages arising from the use or misuse of the information contained herein, its contents or omissions, or otherwise. Copyright © 2024 CIMS. All rights reserved. Powered by CIMSAsia.com